Approval · Notice of Compliance 23645 · 2020
SPRAVATO: Notice of Compliance 23645
Issued May 20, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23645
- Date
- May 20, 2020
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPRAVATO | 02499290 | Marketed |
Medicinal ingredients
- ESKETAMINE HYDROCHLORIDE 28 MG per SPR